Piperidinium 9H-fluorene-9-carbodithioate and its 2,7-di-tert-butyl-substituted analogue [(pipH)(S(2)CCH(C(12)H(6)R(2)-2,7)), R = H (1a), t-Bu (1b)] and 2,7-bis(octyloxy)-9H-fluorene-9-carbodithioic acid [HS(2)CCH(C(12)H(6)(OC(8)H(17))(2)-2,7), 2] and its tautomer [2,7-bis(octyloxy)fluoren-9-ylidene]methanedithiol [(HS)(2)C=C(C(12)H(6)(OC(8)H(17))(2)-2,7), 3] were employed for the preparation of gold complexes with the (fluoren-9-ylidene)methanedithiolato ligand and its substituted analogues. The gold(I) compounds Q(2)[Au(2)(mu-kappa(2)-S,S-S(2)C=C(C(12)H(6)R(2)-2,7))(2)], where Q(+) = PPN(+) or Pr(4)N(+) for R = H (Q(2)4a) or Q(+) = Pr(4)N(+) for R = OC(8)H(17) [(Pr(4)N)(2)4c], were synthesized by reacting Q[AuCl(2)] with 1a or 2 (1:1) and excess piperidine or diethylamine. Complexes of the type [(Au(PR'3))(2)(mu-kappa(2)-S,S-S(2)C=C(C(12)H(6)R(2)-2,7))(2)] with R = H and R' = Me (5a), Et (5b), Ph (5c), and Cy (5d) or R = t-Bu and R' = Me (5e), Et (5f), Ph (5g), and Cy (5h) were obtained by reacting [AuCl(PR'(3))] with 1a,b (1:2) and piperidine. The reactions of 1a,b or 2 with Q[AuCl(4)] (2:1) and piperidine or diethylamine gave Q[Au(kappa(2)-S,S-S(2)C=C(C(12)H(6)R(2)-2,7))(2)] with Q(+) = PPN(+) for R = H [(PPN)6a], Q(+) = PPN(+) or Bu(4)N(+) for R = t-Bu (Q6b), and Q(+) = Bu(4)N(+) for R = OC(8)H(17) [(Bu(4)N)6c]. Complexes Q6a-c reacted with excess triflic acid to give [Au(kappa(2)-S,S-S(2)C=C(C(12)H(6)R(2)-2,7))(kappa(2)-S,S-S(2)CCH(C(12)H(6)R(2)-2,7))] [R = H (7a), t-Bu (7b), OC(8)H(17) (7c)]. By reaction of (Bu(4)N)6b with PhICl(2) (1:1) the complex Bu(4)N[AuCl(2)(kappa(2)-S,S-S(2)C=C(C(12)H(6)(t-Bu)(2)-2,7))] [(Bu(4)N)8b] was obtained. The dithioato complexes [Au(SC(S)CH(C(12)H(8)))(PCy(3))] (9) and [Au(n)(S(2)CCH(C(12)H(8)))(n)] (10) were obtained from the reactions of 1a with [AuCl(PCy(3))] or [AuCl(SMe(2))], respectively (1:1), in the absence of a base. Charge-transfer adducts of general composition Q[Au(kappa(2)-S,S-S(2)C=C(C(12)H(6)R(2)-2,7))(2)].1.5TCNQ.xCH(2)Cl(2) [Q(+) = PPN(+), R = H, x = 0 (11a); Q(+) = PPN(+), R = t-Bu, x = 2 (11b); Q(+) = Bu(4)N(+), R = OC(8)H(17), x = 0 (11c)] were obtained from Q6a-c and TCNQ (1:2). The crystal structures of 5c.THF, 5e.(2)/(3)CH(2)Cl(2), 5g.CH(2)Cl(2), (PPN)6a.2Me(2)CO, and 11b were solved by X-ray diffraction studies. All the gold(I) complexes here described are photoluminescent at 77 K, and their emissions can be generally ascribed to LMMCT (Q(2)4a,c, 5a-h, 10) or LMCT (9) excited states.

The reaction of [Cu(NCMe) 4 ]PF 6 with piperidinium 2,7-ditert-butyl-9H-fluorene-9-carbodithioate (pipH)[S 2 C(tBuHfy)] (1; tBu-Hfy = 2,7-di-tert-butylfluoren-9-yl), affords [Cu n {S 2 C(tBu-Hfy)} n ] (2), which reacts with various P ligands to give [Cu{S 2 C(tBu-

The Cu(III) complex Pr 4N[Cu{S 2C=( t-Bu-fy)} 2] ( 1) ( t-Bu-fy = 2,7-di- tert-butylfluoren-9-ylidene) reacts with [Cu(PR 3) 4]ClO 4 in 1:1 molar ratio in MeCN to give the dinuclear complexes [Cu 2{[SC=( t-Bu-fy)] 2S}(PR 3) n ] [ n = 2, R = Ph ( 2a); n = 3, R = To ( 3b); To = p-tolyl]. The analogue of 2a with R = To ( 2b) can be obtained from the reaction of 3b with 1/8 equiv of S 8. Compound 2b establishes a thioketene-exchange equilibrium in solution leading to the formation of [Cu 4{S 2C=( t-Bu-fy)} 2(PTo 3) 4] ( 4b) and [Cu 2{[SC=( t-Bu-fy)] 3S}(PTo 3) 2] ( 5b). Solid mixtures of 4b and 5b in varying proportions can be obtained when the precipitation of 2b is attempted using MeCN. The reactions of 1 with AgClO 4 and PPh 3, PTo 3 or PCy 3 in 1:1:4 molar ratio in MeCN afford the heterodinuclear complexes [AgCu{[SC=( t-Bu-fy)] 2S}(PR 3) 3] [R = Ph ( 6a), To ( 6b), Cy ( 6c)]. Complex 6c dissociates PCy 3 in solution to give the bis(phosphine) derivative [AgCu{[SC=( t-Bu-fy)] 2S}(PCy 3) 2] ( 7c), which undergoes the exchange of [M(PCy 3)] (+) units in CD 2Cl 2 solution to give small amounts of [Cu 2{[SC=( t-Bu-fy)] 2S}(PCy 3) 2] ( 2c) and [Ag 2{[SC=( t-Bu-fy)] 2S}(PCy 3) 2] ( 8c). Complexes 6a and b participate in a series of successive equilibria in solution, involving the dissociation of phosphine ligands and the exchange of [M(PCy 3)] (+) units to give 2a or 3b and the corresponding disilver derivatives [Ag 2{[SC=( t-Bu-fy)] 2S}(PR 3) 2] [R = Ph ( 8a), To ( 8b)], followed by thioketene-exchange reactions to give [AgCu{[SC=( t-Bu-fy)] 3S}(PR 3) 2] [R = Ph ( 9a), To ( 9b)]. Complexes 9a and b can be directly prepared from the reactions of 1 with AgClO 4 and PPh 3 or PTo 3 in 1:1:3 molar ratio in THF. The crystal structures of 3b, 6b, 6c, 7c, and 9a have been solved by single-crystal X-ray diffraction studies and, in the cases of 7c and 9a, reveal the formation of short Ag...Cu metallophilic contacts of 2.8157(4) and 2.9606(6) A, respectively.

No abstract

The reaction of AgClO(4) with piperidinium 2,7-di-tert-butyl-9H-fluorene-9-carbodithioate (pipH)[S(2)C(t-Bu-Hfy)] (1) (t-Bu-Hfy = 2,7-di-tert-butylfluoren-9-yl) afforded [Ag(n){S(2)C(t-Bu-Hfy)}(n)] (2), which reacted with phosphines to give [Ag{S(2)C(t-Bu-Hfy)}L(2)] [L = PPh(3) (3a); L(2) = bis(diphenylphosphino)ethane (dppe, 3b), 1,1'-bis(diphenylphosphino)ferrocene (dppf, 3c). By reacting complex 2 with AgClO(4) and piperidine in a 1:1:1 molar ratio, the dodecanuclear cluster [Ag(12){S(2)C(t-Bu-fy)}(6)] (4) (t-Bu-fy = 2,7-di-tert-butylfluoren-9-ylidene) was obtained. Compound 4 can also be directly prepared from the reaction of 1 with AgClO(4) and piperidine in a 1:2:1 molar ratio. The reactions of 1 with AgClO(4), phosphines, and piperidine afforded the compounds [Ag(6){S(2)C(t-Bu-fy)}(3)L(5)] [1:2:2:1 molar ratio; L = PPh(3) (5a), P(p-To)(3) (5b)], [Ag(4){S(2)C(t-Bu-fy)}(2)(dppf)(2)] (6) (1:2:1:1 molar ratio), [Ag(n){S(2)C(t-Bu-fy)}(n/2){P(i-Pr)(3)}(n)] (7) (1:2:2:1 molar ratio), or [Ag(8){S(2)C(t-Bu-fy)}(4){P(i-Pr)(3)}(4)] (8) (1:2:1:1 molar ratio). Complexes 5a,b, 6, 7, and 8 can be also obtained by reacting 4 with the corresponding phosphine in the appropriate molar ratio. The crystal structures of 4, 5b, and 8 have been determined by X-ray diffraction studies. The nuclearity of complex 6 was established from its (31)P{(1)H} NMR data, which reveal a very fast dynamic process leading to an average coupling of each of the P atoms of the dppf ligands with four Ag atoms.

CR treatment increased both global quality of life and the four domains of the Cervantes HR-QoL scale, being an effective treatment to reduce symptoms in post-menopausal woman with elevated body weight.